Immutep Ltd ADR (NQ: IMMP )

2.710 USD -0.040 (-1.45%)

Official Closing Price Updated: 7:29 PM EST, Mar 2, 2021 Add to My Watchlist

Price and Volume

Volume	271,377
Open	2.760
Bid (Size)	2.700 (5)
Ask (Size)	2.770 (7)
Prev. Close	2.750
Today's Range	2.700 - 2.801
52wk Range	0.5300 - 7.950
Shares Outstanding	23,993,291
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study

January 27, 2021

Immutep Quarterly Activities Report

January 21, 2021

Performance

YTD	-12.01%	-12.01%
1 Month	-8.45%	-8.45%
3 Month	+35.50%	+35.50%
6 Month	+106.87%	+106.87%
1 Year	+8.40%	+8.40%

More News

Ulcerative Colitis Phase II Study of GSK2831781 Discontinued

January 21, 2021

Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study

January 06, 2021

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch

December 30, 2020

Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor

December 29, 2020

Immutep Upscales Efti Manufacturing

December 16, 2020

Immutep Operational Update

December 15, 2020

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

December 30, 2020

The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement

January 27, 2021

The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa

January 22, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.